Skip to main content

Table 1 Baseline characteristics.

From: Sympathetic hyperactivity influences chemosensor function in patients with end-stage renal disease

  Controls
(n = 10)
ESRD
(n = 10)
Age, yr 62 ± 6 65 ± 4
Male sex, n 6 6
Hx hypertension, n 7 7
Hx dyslipidemia, n 8 7
Hx smoking, n 6 5
Hx CAD, n 5 4
Hx CVD, n 4 1
Hemoglobin, g/l 132 ± 7 126 ± 4
Medication, n (%)
   Alpha-blockers 3 1
   Beta-blockers 6 5
   ACE-inhibitors/AT-II-antagonists 6 6
   Calcium antagonists 5 2
   Central sympatholytic agents 0 2
   Isosorbide dinitrate 3 1
   Diuretics 7 5
   Statins 7 5
  1. Hx, indicates history of; CAD, coronary artery disease; CVD, cerebrovascular disease; Values are means ± SE.